Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
CLPT ClearPoint Neuro	$11.68 -2.0%	$11.47	$9.46 ▼ $19.22	$338.86M	0.85	390,052 shs	511,212 shs
MBOT Microbot Medical	$3.13 +3.0%	$2.62	$0.82 ▼ $3.38	$138.46M	1.15	2.35 million shs	2.21 million shs
NPCE NeuroPace	$9.03 -3.1%	$10.00	$5.45 ▼ $18.98	$308.32M	1.89	198,762 shs	180,080 shs
OM Outset Medical	$12.89 -2.4%	$18.13	$5.85 ▼ $25.35	$234.69M	2.14	365,614 shs	196,947 shs

10 Stocks Set to Soar in Fall 2025

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
CLPT ClearPoint Neuro	-2.01%	+6.96%	+4.75%	-11.38%	+18.82%
MBOT Microbot Medical	+2.96%	+7.19%	+26.21%	+16.79%	+216.16%
NPCE NeuroPace	-3.11%	+1.23%	-3.42%	-48.37%	+33.38%
OM Outset Medical	-2.42%	-9.10%	-28.71%	-33.90%	+3.16%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
CLPT ClearPoint Neuro	1.7282 of 5 stars	3.5	1.0	1.7	0.8	0.6
MBOT Microbot Medical	1.6432 of 5 stars	3.5	1.0	2.1	0.0	0.6
NPCE NeuroPace	3.1616 of 5 stars	3.5	3.0	2.2	3.3	0.6
OM Outset Medical	1.7737 of 5 stars	3.5	2.0	2.1	0.8	0.0

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
CLPT ClearPoint Neuro	3.00	Buy	$19.67	68.38% Upside
MBOT Microbot Medical	3.00	Buy	$9.00	187.54% Upside
NPCE NeuroPace	3.00	Buy	$16.60	83.83% Upside
OM Outset Medical	3.00	Buy	$24.67	91.36% Upside

Current Analyst Ratings Breakdown

Latest MBOT, OM, NPCE, and CLPT Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
8/13/2025	NPCE NeuroPace	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Overweight ➝ Overweight	$17.00 ➝ $15.00
8/7/2025	OM Outset Medical	Royal Bank Of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Sector Perform ➝ Sector Perform	$21.00 ➝ $22.00
8/1/2025	CLPT ClearPoint Neuro	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$8.00 ➝ $9.00
7/14/2025	OM Outset Medical	BTIG Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Price Target	Buy ➝ Buy	$37.00
5/28/2025	NPCE NeuroPace	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy	$18.00
5/21/2025	OM Outset Medical	Royal Bank Of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Sector Perform ➝ Sector Perform	$14.00 ➝ $21.00
5/15/2025	OM Outset Medical	Scotiabank Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Strong-Buy

(Data available from 8/15/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
CLPT ClearPoint Neuro	$31.39M	10.58	N/A	N/A	$0.69 per share	16.93
MBOT Microbot Medical	N/A	N/A	N/A	N/A	$0.67 per share	N/A
NPCE NeuroPace	$79.91M	3.74	N/A	N/A	$0.59 per share	15.31
OM Outset Medical	$113.69M	2.01	N/A	N/A	$8.50 per share	1.52

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
CLPT ClearPoint Neuro	-$18.91M	-$0.81	N/A	N/A	N/A	-66.15%	-94.44%	-51.58%	N/A
MBOT Microbot Medical	-$11.44M	-$0.58	N/A	N/A	N/A	N/A	-76.27%	-67.54%	N/A
NPCE NeuroPace	-$27.14M	-$0.84	N/A	N/A	N/A	-29.29%	-168.61%	-25.48%	N/A
OM Outset Medical	-$127.98M	-$20.29	N/A	∞	N/A	-82.06%	-97.17%	-32.84%	N/A

Latest MBOT, OM, NPCE, and CLPT Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/12/2025	Q2 2025	CLPT ClearPoint Neuro	-$0.20	-$0.21	-$0.01	-$0.21	$9.20 million	$9.22 million
8/12/2025	Q2 2025	MBOT Microbot Medical	-$0.08	-$0.10	-$0.02	-$0.10	$1.00 million	N/A
8/12/2025	Q2 2025	NPCE NeuroPace	-$0.24	-$0.26	-$0.02	-$0.26	$23.08 million	$23.52 million
5/21/2025	Q1 2025	MBOT Microbot Medical	-$0.15	-$0.08	+$0.07	-$0.08	N/A	N/A

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
CLPT ClearPoint Neuro	N/A	N/A	N/A	N/A	N/A
MBOT Microbot Medical	N/A	N/A	N/A	N/A	N/A
NPCE NeuroPace	N/A	N/A	N/A	N/A	N/A
OM Outset Medical	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
CLPT ClearPoint Neuro	1.46	7.30	2.57
MBOT Microbot Medical	N/A	12.06	16.19
NPCE NeuroPace	3.02	5.47	5.70
OM Outset Medical	0.63	7.47	6.05

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
CLPT ClearPoint Neuro	30.08%
MBOT Microbot Medical	16.30%
NPCE NeuroPace	78.83%
OM Outset Medical	N/A

Insider Ownership

Company	Insider Ownership
CLPT ClearPoint Neuro	6.97%
MBOT Microbot Medical	4.74%
NPCE NeuroPace	20.50%
OM Outset Medical	2.40%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
CLPT ClearPoint Neuro	110	28.43 million	26.04 million	Optionable
MBOT Microbot Medical	20	45.55 million	34.65 million	Optionable
NPCE NeuroPace	170	33.08 million	26.08 million	Optionable
OM Outset Medical	520	17.77 million	17.34 million	Not Optionable

MBOT, OM, NPCE, and CLPT Headlines

Recent News About These Companies

Outset Medical (NASDAQ:OM) Stock Price Expected to Rise, Royal Bank Of Canada Analyst Says

August 8, 2025 | marketbeat.com

Outset Medical Reports Strong Q2 Growth and Raises Guidance

August 7, 2025 | msn.com

What To Expect From Outset Medical Inc (OM) Q2 2025 Earnings

August 7, 2025 | finance.yahoo.com

Outset Medical, Inc. (OM) Q2 2025 Earnings Call Transcript

August 6, 2025 | seekingalpha.com

Outset Medical, Inc. (OM) Reports Q2 Loss, Beats Revenue Estimates

August 6, 2025 | zacks.com

Outset Medical Second-Quarter Results Demonstrate Continued Momentum, Punctuated by Strong Revenue Growth, Console Placements and Utilization

August 6, 2025 | globenewswire.com

Uncovering Potential: Outset Medical's Earnings Preview

August 5, 2025 | benzinga.com

TD Asset Management Inc Acquires New Stake in Outset Medical, Inc. (NASDAQ:OM)

August 5, 2025 | marketbeat.com

Outset Medical (OM) to Release Earnings on Wednesday

August 5, 2025 | americanbankingnews.com

Outset Medical Appoints Brittni McGill as Chief Nursing Officer to Enhance Dialysis Care Innovation

July 30, 2025 | quiverquant.comQ

Outset Medical Names First Chief Nursing Officer

July 30, 2025 | globenewswire.com

Outset Medical (OM) Projected to Post Earnings on Wednesday

July 30, 2025 | marketbeat.com

840,248 Shares in Outset Medical, Inc. (NASDAQ:OM) Acquired by Massachusetts Financial Services Co. MA

July 20, 2025 | marketbeat.com

C WorldWide Group Holding A S Sells 933,334 Shares of Outset Medical, Inc. (NASDAQ:OM)

July 18, 2025 | marketbeat.com

Outset Medical to Report Second Quarter 2025 Financial Results on Wednesday, August 6, 2025

July 16, 2025 | globenewswire.com

Why Outset Medical's Rock-Bottom Valuation Masks Explosive Growth

July 7, 2025 | seekingalpha.com

Strength Seen in Outset Medical (OM): Can Its 15.0% Jump Turn into More Strength?

June 25, 2025 | zacks.com

Outset Medical, Inc. (OM) - Yahoo Finance

June 24, 2025 | finance.yahoo.com

Outset Medical to Present at the Goldman Sachs 46th Annual Global Healthcare Conference

June 5, 2025 | globenewswire.com

Former Shockwave CFO joins Outset Medical in the same role

June 4, 2025 | massdevice.com

Outset Medical Appoints Renee Gaeta as Chief Financial Officer

June 3, 2025 | globenewswire.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

MBOT, OM, NPCE, and CLPT Company Descriptions

ClearPoint Neuro NASDAQ:CLPT

$11.68 -0.24 (-2.01%)

Closing price 08/14/2025 04:00 PM Eastern

Extended Trading

$11.58 -0.11 (-0.90%)

As of 04:47 AM Eastern

ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under magnetic resonance imaging guided interventions. The company offers ClearPoint system, an integrated system for the insertion of deep brain stimulation electrodes, biopsy needles, and laser catheters, as well as the infusion of pharmaceuticals into the brain. It has license and collaboration agreement with Clinical Laserthermia Systems AB; license and research agreement with Koninklijke Philips N.V., UCB Biopharma SRL, and University of California and San Francisco; and development and license agreement with NE Scientific, LLC. The company was formerly known as MRI Interventions, Inc. and changed its name to ClearPoint Neuro, Inc. in February 2020. ClearPoint Neuro, Inc. was incorporated in 1998 and is headquartered in Solana Beach, California.

Microbot Medical NASDAQ:MBOT

$3.13 +0.09 (+2.96%)

Closing price 08/14/2025 04:00 PM Eastern

Extended Trading

$3.10 -0.03 (-0.96%)

As of 06:14 AM Eastern

Microbot Medical Inc., a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination for use in cardiovascular, peripheral, and neurovascular spaces. It also provides NovaCross, an intellectual property and technology in the field of intraluminal revascularization devices with anchoring mechanism and integrated microcatheter. The company has a strategic collaboration agreement with Stryker Corporation for technology co-development. Microbot Medical Inc. was founded in 2010 and is based in Braintree, Massachusetts.

NeuroPace NASDAQ:NPCE

$9.03 -0.29 (-3.11%)

Closing price 08/14/2025 04:00 PM Eastern

Extended Trading

$9.02 -0.01 (-0.11%)

As of 05:33 AM Eastern

NeuroPace, Inc. operates as a medical device company in the United States. The company develops RNS system, a brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source for treating medically refractory focal epilepsy. It also records continuous brain activity data and enables clinicians to monitor patients in person and remotely. Its RNS System includes RNS neurostimulator, cortical strip and depth leads, and Patient Remote Monitor, as well as other implantable and non-implantable accessories. The company sells its products to hospital facilities for initial RNS system implant procedures and for replacement procedures. NeuroPace, Inc. was incorporated in 1997 and is headquartered in Mountain View, California.

Outset Medical NASDAQ:OM

$12.89 -0.32 (-2.42%)

Closing price 08/14/2025 04:00 PM Eastern

Extended Trading

$12.78 -0.11 (-0.81%)

As of 08/14/2025 04:50 PM Eastern

Outset Medical, Inc., a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company offers Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables. It also provides Tablo Data Ecosystem, including TabloHub, a customer-facing portal; MyTablo, a patient-facing portal; and TabloDash, an internal data analytics platform. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time